Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 15, 2014Annals of the Rheumatic DiseasesOpen Access

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis

View Full Paper
Ask AI
Bookmark
Share

Authors

DBD L BoyleKSK. SomaJHJ Hodge

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Boyle et al. (2014) studied this question.

synapsesocial.com/papers/6a761ae49aebbbed36614212https://doi.org/10.1136/annrheumdis-2014-206028
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Quantitative biomarker analysis of synovial gene expression by real-time PCR2003 · 134 citations
  2. 2The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis1988 · 19,985 citations
  3. 3Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis2012 · 948 citations
  4. 4A phase II, randomized, double‐blind, placebo‐controlled study evaluating the efficacy and safety of MDX‐1100, a fully human anti‐CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis2011 · 197 citations